Wilmington, DE -- (SBWIRE) -- 11/01/2013 -- Equity Profile Report expands its NYSE Decliners Weekly Watch List adding Merck & Co. Inc. (NYSE:MRK) and Goldcorp Inc. (NYSE:GG).
Merck & Co. Inc. (NYSE:MRK) a company that provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide closed down in its previous session (-0.33%) on 14,994,218 shares traded after Merck Announced Presentation of Interim Data from Phase 1B Study of MK-3475, Investigational anti-PD-1 Immunotherapy, in Previously-Treated Patients with Non-Small Cell Lung Cancer at 15th World Conference on Lung Cancer. Merck & Co. Inc. (NYSE:MRK) is currently down (-10.11%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Decliners Watch List.
Click Here to find out what other Investors are saying about Merck & Co. Inc. (NYSE:MRK)
Goldcorp Inc. (NYSE:GG) a company that engages in the acquisition, development, exploration, and operation of precious metal properties in Canada, the United States, Mexico, and Central and South America closed down in its previous session (-3.49%) on 8,620,027 shares traded after Goldcorp was downgraded to Neutral from Overweight at HSBC Securities. Goldcorp Inc. (NYSE:GG) is currently down (-44.33%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Decliners Watch List.
Click Here to find out what other Investors are saying about Goldcorp Inc. (NYSE:GG)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)